Anna Haemel, MD, FAAD
SESSIONS
F051 Advanced Management of the Dermatologic Manifestations of Connective Tissue Diseases
Mar 9, 2024
•
1:00 PM - 12:00 AM
•
Room 32B
F098 Monitoring Guidelines for Immunomodulatory Drug Therapy
Mar 11, 2024
•
9:00 AM - 12:00 AM
•
Room 1B
DISCLOSURES
AstraZeneca – Investigator(Fees); Celldex – Investigator(Grants/Research Funding); CSL Behring – Data Safety Monitoring Board(Honoraria); Eli Lilly – Stockholder Public Company(Stock); Galderma – Investigator(Grants/Research Funding); Insmed – Investigator(Fees); Priovant Therapeutics – Advisory Board(Honoraria), Investigator(Fees);